GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML) - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 88086496
Serial Number
88086496
Registration Number
6169996
Word Mark
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML)
Status
700 - Registered
Status Date
2020-10-06
Filing Date
2018-08-21
Registration Number
6169996
Registration Date
2020-10-06
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
261113, 261121, 261709 - Two rectangles. Rectangles that are completely or partially shaded. Curved line(s), band(s) or bar(s).
Published for Opposition Date
2019-01-29
Attorney Name
Keith Barritt
Law Office Assigned Location Code
N40
Employee Name
GANESH, HARINI
Statements
Indication of Colors claimed
The color(s) brown, white and black is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML)
Description of Mark
The mark consists of a brown outline of a rectangle surrounding the word "GEMCITABINE" in black lettering above the words "in 0.9% sodium chloride injection" along with a brown arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle filled in brown, with the words "1,200 mg per 120 mL (10 mg/mL)" in white letters. The color white in the rectangle with the arched curve represents background only and is not claimed as a feature of the mark.
Goods and Services
medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine
Goods and Services
medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine
Pseudo Mark
GEMCITABINE IN 0. NINE PERCENT SODIUM CHLORIDE INJECTION ONE, THOUSAND TWO HUNDRED MG PER ONE HUNDRED ML (TEN MG/ML)
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-08-29
Primary Code
005
First Use Anywhere Date
2020-07-08
First Use In Commerce Date
2020-07-08
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2018-08-29
Primary Code
010
First Use Anywhere Date
2020-07-08
First Use In Commerce Date
2020-07-08
Current Trademark Owners
Party Name
Sun Pharmaceutical Industries Limited
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Sun Pharmaceutical Industries Limited
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Sun Pharmaceutical Industries Limited
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Sun Pharmaceutical Industries Limited
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Keith Barritt
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-08-24NEW APPLICATION ENTERED IN TRAM
2018-08-29NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-08-30NOTICE OF DESIGN SEARCH CODE E-MAILED
2018-11-27ASSIGNED TO EXAMINER
2018-11-29EXAMINERS AMENDMENT -WRITTEN
2018-11-29EXAMINERS AMENDMENT E-MAILED
2018-11-29NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2018-11-29EXAMINER'S AMENDMENT ENTERED
2018-11-29APPROVED FOR PUB - PRINCIPAL REGISTER
2018-12-21ASSIGNED TO LIE
2019-01-09NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-01-29PUBLISHED FOR OPPOSITION
2019-01-29OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-03-26NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2019-09-19TEAS EXTENSION RECEIVED
2019-09-19EXTENSION 1 FILED
2019-09-19EXTENSION 1 GRANTED
2019-09-21NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-03-18TEAS EXTENSION RECEIVED
2020-03-18EXTENSION 2 FILED
2020-03-18EXTENSION 2 GRANTED
2020-03-20NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-08-04TEAS STATEMENT OF USE RECEIVED
2020-08-13CASE ASSIGNED TO INTENT TO USE PARALEGAL
2020-08-04USE AMENDMENT FILED
2020-08-13STATEMENT OF USE PROCESSING COMPLETE
2020-09-02ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2020-09-03NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2020-10-06REGISTERED-PRINCIPAL REGISTER